Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen J Adams, PJ Carder, S Downey, MA Forbes, K MacLennan, V Allgar, ... Cancer research 60 (11), 2898-2905, 2000 | 545 | 2000 |
Breast cancer cell lines: friend or foe? SE Burdall, AM Hanby, MRJ Lansdown, V Speirs Breast cancer research 5, 1-7, 2003 | 518 | 2003 |
Gastric cancer: a curable disease in Britain. HM Sue-Ling, D Johnston, IG Martin, MF Dixon, MR Lansdown, ... British Medical Journal 307 (6904), 591-596, 1993 | 320 | 1993 |
Reduced expression of oestrogen receptor β in invasive breast cancer and its re‐expression using DNA methyl transferase inhibitors in a cell line model GP Skliris, K Munot, SM Bell, PJ Carder, S Lane, K Horgan, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003 | 277 | 2003 |
Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism CN Patel, HM Salahudeen, M Lansdown, AF Scarsbrook Clinical radiology 65 (4), 278-287, 2010 | 252 | 2010 |
High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. M Lansdown, P Quirke, MF Dixon, AT Axon, D Johnston Gut 31 (9), 977-983, 1990 | 204 | 1990 |
Oestrogen receptor β: what it means for patients with breast cancer V Speirs, PJ Carder, S Lane, D Dodwell, MRJ Lansdown, AM Hanby The lancet oncology 5 (3), 174-181, 2004 | 184 | 2004 |
Short-term safety outcomes of mastectomy and immediate implant-based breast reconstruction with and without mesh (iBRA): a multicentre, prospective cohort study S Potter, EJ Conroy, RI Cutress, PR Williamson, L Whisker, S Thrush, ... The Lancet Oncology 20 (2), 254-266, 2019 | 183 | 2019 |
Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations RE Coleman, WW Bolten, M Lansdown, S Dale, C Jackisch, D Merkel, ... Cancer treatment reviews 34 (3), 275-282, 2008 | 148 | 2008 |
Immunohistochemical detection of ERβ in breast cancer: towards more detailed receptor profiling? GP Skliris, PJ Carder, MRJ Lansdown, V Speirs British journal of cancer 84 (8), 1095-1098, 2001 | 115 | 2001 |
Sentinel lymph node biopsy in male breast cancer patients A Goyal, K Horgan, M Kissin, C Yiangou, M Sibbering, M Lansdown, ... European Journal of Surgical Oncology (EJSO) 30 (5), 480-483, 2004 | 112 | 2004 |
Culture, attitude and knowledge about breast cancer and preventive measures: a qualitative study of South Asian breast cancer patients in the UK G Karbani, JN Lim, J Hewison, K Atkin, K Horgan, M Lansdown, CE Chu Asian Pac J Cancer Prev 12 (6), 1619-26, 2011 | 105 | 2011 |
Steroid hormone receptor expression in male breast cancer CE Murphy, PJ Carder, MRJ Lansdown, V Speirs European Journal of Surgical Oncology (EJSO) 32 (1), 44-47, 2006 | 88 | 2006 |
Teaching laparoscopic surgery: the need for guidelines CMS Royston, MRJ Lansdown, WA Brough Bmj 308 (6935), 1023-1025, 1994 | 87 | 1994 |
The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment S Duffy, TL Jackson, M Lansdown, K Philips, M Wells, S Pollard, G Clack, ... Human Reproduction 21 (2), 545-553, 2006 | 84 | 2006 |
Effect of neoadjuvant chemotherapy on breast cancer phenotype, ER/PR and HER2 expression–Implications for the practising oncologist R Gahlaut, A Bennett, H Fatayer, BJ Dall, N Sharma, G Velikova, T Perren, ... European Journal of Cancer 60, 40-48, 2016 | 79 | 2016 |
Helicobacter gastritis and intestinal metaplasia in a gastric cancer family N Scott, R Diament, V Murday, M McMahon, M Lansdown, B Rathbone, ... The Lancet 335 (8691), 728, 1990 | 70 | 1990 |
For Better, for Worse?: A Review of the Care of Patients who Died Within 30 Days of Receiving Systemic Anti-cancer Therapy: a Report by the National Confidential Enquiry Into … National Confidential Enquiry into Patient Outcome and Death, D Mort National Confidential Enquiry into Patient Outcome and Death, 2008 | 68 | 2008 |
Changes in and predictors of length of stay in hospital after surgery for breast cancer between 1997/98 and 2004/05 in two regions of England: a population-based study A Downing, M Lansdown, RM West, JD Thomas, G Lawrence, D Forman BMC health services research 9, 1-9, 2009 | 51 | 2009 |
Surgical pathological second opinion in thyroid malignancy: impact on patients' management and prognosis ZZR Hamady, N Mather, MR Lansdown, L Davidson, KA Maclennan European Journal of Surgical Oncology (EJSO) 31 (1), 74-77, 2005 | 50 | 2005 |